[Archived] INH and Rifapentine Treatment for LTBI: Expert Opinions About 3HP Utilization

This training has no registration dates yet

Remote video URL

90-Minute National Webinar
Originally aired March 17, 2016

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Webinar Materials: www.currytbcenter.ucsf.edu/trainings/3hp-webinar-materials/materials

This 90-minute training was created for physicians, nurses, and other health professionals who diagnose and treat patients with latent TB infection (LTBI).

The webinar will include a panel of experts discussing the questions healthcare providers have about using 3 months of isoniazid and rifapentine once weekly (3HP) to treat LTBI.

Please note:  This presentation contains information about the treatment of latent tuberculosis infection (LTBI). It was produced prior to the release of updated guidelines from the CDC in February 2020.  For the most current guidance available regarding LTBI treatment, please see: Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020

*CME and CE units are not being offered for this recording and there is no participant evaluation.

Faculty:

Heidi Behm, RN, MPH
TB Controller 
Public Health Division
Oregon Health Authority
Portland, OR

Marcos Burgos, MD
Associate Professor/TB Medical Director
TB Control Program
New Mexico Department of Health
Albuquerque, NM

Neha Shah, MD, MPH
Commander, US Public Health Service
Centers for Disease Control and Prevention
California Department of Public Health
Richmond, CA

Mai Vu, Pharm D
Pharmacist
Infectious Diseases Section
San Francisco VA Medical Center
San Francisco, CA

 

Course Dates
-
Training Format
Webinar
Total Hours
1.50
Location

United States